I concur Portsmouth ....... if results are good further down the line, then the big money will be the disease management ... If your charging someone $100 a year, maybe the net is $60 (tax and expenses) ... 20m people globally ( not hard to envisage, and saving them and the respective health systems huge money). ... Suggests an npat of a$1.2bn per year ... A pe multiple of 10 would suggest 12bn market cap, or 15$ per share .. Anything is possible
RAP Price at posting:
30.5¢ Sentiment: Buy Disclosure: Held